金达威：美国加征关税对公司的生产经营不会产生较大的影响

Core Viewpoint - The company assesses that the recent increase in tariffs by the United States will not significantly impact its production and operations [1] Summary by Relevant Categories Impact of Tariffs - The company's primary export product to the U.S. is coenzyme Q10, with an export value of 326 million yuan for the year 2024, accounting for 10.06% of its main business revenue [1] - Coenzyme Q10 is included in the tariff exemption list, with the applicable total tariff rate currently at 20% [1] Other Export Products - The company also exports vitamin A, vitamin D3, and vitamin K2 to the U.S., with an export value of 39 million yuan, which also falls under the exemption category, maintaining the same 20% tariff rate [1] Business Strategy - The company plans to offset the impact of tariffs by increasing product prices and is closely monitoring related developments to ensure stable operations [1]